A generic medicine indicated for bacterial infections. Addresses active infections by preventing the synthesis of bacterial RNA, effectively halting the multiplication process of the target pathogens.
Information related to Rifadin is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.